Literature DB >> 24337962

Cumulative live-birth rate in women with polycystic ovary syndrome or isolated polycystic ovaries undergoing in-vitro fertilisation treatment.

Hang Wun Raymond Li1, Vivian Chi Yan Lee, Estella Yee Lan Lau, William Shu Biu Yeung, Pak Chung Ho, Ernest Hung Yu Ng.   

Abstract

PURPOSE: This retrospective cohort study evaluated the cumulative live birth rate in women with polycystic ovary syndrome (PCOS) and isolated polycystic ovaries (PCO) undergoing in-vitro fertilisation (IVF) treatment.
METHODS: We studied 104 women with PCOS, 184 with PCO and 576 age-matched controls undergoing the first IVF treatment cycle between 2002 and 2009. The main outcome measure was cumulative live birth in the fresh plus all the frozen embryo transfers combined after the same stimulation cycle.
RESULTS: Women in both the PCOS (n = 104) and isolated PCO groups (n = 184) had higher ovarian response parameters compared to age-matched controls (n = 576), and higher rates of withholding fresh embryo transfer for risk of ovarian hyperstimulation syndrome (OHSS). The actual incidence of moderate to severe OHSS was significantly higher in the PCOS (11.5 %) but not the isolated PCO group (8.2%) compared to controls (4.9%). The live birth rates in the fresh cycle were comparable among the 3 groups, but the PCOS group had a significantly higher miscarriage rate compared to the other 2 groups. Cumulative live birth rate was significantly higher in the isolated PCO group (60.3%), but not the PCOS group (50.0%), compared to controls (47.5%).
CONCLUSIONS: Women in the isolated PCO group, but not the PCOS group, had a significantly higher cumulative live birth rate compared to controls. This could be explained by the quantitative effect of the higher number of transferable embryos obtained per stimulation cycle, which is uncompromised by the unfavourable embryo competence otherwise observed in PCOS.

Entities:  

Mesh:

Year:  2013        PMID: 24337962      PMCID: PMC3933606          DOI: 10.1007/s10815-013-0151-6

Source DB:  PubMed          Journal:  J Assist Reprod Genet        ISSN: 1058-0468            Impact factor:   3.412


  22 in total

1.  Polycystic ovaries at ultrasound: normal variant or silent polycystic ovary syndrome?

Authors:  S Catteau-Jonard; J Bancquart; E Poncelet; C Lefebvre-Maunoury; G Robin; D Dewailly
Journal:  Ultrasound Obstet Gynecol       Date:  2012-08       Impact factor: 7.299

2.  IVF outcome in women with PCOS, PCO and normal ovarian morphology.

Authors:  Alexander Swanton; Lisa Storey; Enda McVeigh; Tim Child
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  2009-12-22       Impact factor: 2.435

3.  A meta-analysis of outcomes of conventional IVF in women with polycystic ovary syndrome.

Authors:  E M E W Heijnen; M J C Eijkemans; E G Hughes; J S E Laven; N S Macklon; B C J M Fauser
Journal:  Hum Reprod Update       Date:  2005-08-25       Impact factor: 15.610

4.  Transabdominal versus transvaginal ultrasound in the diagnosis of polycystic ovaries in a population of randomly selected women.

Authors:  C M Farquhar; M Birdsall; P Manning; J M Mitchell
Journal:  Ultrasound Obstet Gynecol       Date:  1994-01-01       Impact factor: 7.299

5.  Comparison of in vitro fertilization outcome in women with and without sonographic evidence of polycystic ovarian morphology.

Authors:  Seddigheh Esmailzadeh; Mahbobeh Faramarzi; Gholamali Jorsarai
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  2005-01-19       Impact factor: 2.435

Review 6.  Ultrasound assessment of the polycystic ovary: international consensus definitions.

Authors:  Adam H Balen; Joop S E Laven; Seang-Lin Tan; Didier Dewailly
Journal:  Hum Reprod Update       Date:  2003 Nov-Dec       Impact factor: 15.610

7.  Consensus on infertility treatment related to polycystic ovary syndrome.

Authors: 
Journal:  Hum Reprod       Date:  2008-03       Impact factor: 6.918

Review 8.  Extra- and intra-ovarian factors in polycystic ovary syndrome: impact on oocyte maturation and embryo developmental competence.

Authors:  Jie Qiao; Huai L Feng
Journal:  Hum Reprod Update       Date:  2010-07-16       Impact factor: 15.610

9.  Comparison of Endocrine Profile and In Vitro Fertilization Outcome in Patients with PCOS, Ovulatory PCO, or Normal Ovaries.

Authors:  Yi-Ping Zhong; Ying Ying; Hai-Tao Wu; Can-Quan Zhou; Yan-Wen Xu; Qiong Wang; Jie Li; Xiao-Ting Shen; Jin Li
Journal:  Int J Endocrinol       Date:  2012-02-28       Impact factor: 3.257

10.  Role of baseline antral follicle count and anti-Mullerian hormone in prediction of cumulative live birth in the first in vitro fertilisation cycle: a retrospective cohort analysis.

Authors:  Hang Wun Raymond Li; Vivian Chi Yan Lee; Estella Yee Lan Lau; William Shu Biu Yeung; Pak Chung Ho; Ernest Hung Yu Ng
Journal:  PLoS One       Date:  2013-04-23       Impact factor: 3.240

View more
  14 in total

Review 1.  Polycystic ovary syndrome throughout a woman's life.

Authors:  José Bellver; Luis Rodríguez-Tabernero; Ana Robles; Elkin Muñoz; Francisca Martínez; José Landeras; Juan García-Velasco; Juan Fontes; Mónica Álvarez; Claudio Álvarez; Belén Acevedo
Journal:  J Assist Reprod Genet       Date:  2017-09-27       Impact factor: 3.412

2.  How to manage the reproductive issues of PCOS: a 2015 integrated endocrinological and gynecological consensus statement of the Italian Society of Endocrinology.

Authors:  P Moghetti; E Carmina; V De Leo; A Lanzone; F Orio; R Pasquali; V Toscano
Journal:  J Endocrinol Invest       Date:  2015-04-03       Impact factor: 4.256

3.  NMR metabolic profiling of follicular fluid for investigating the different causes of female infertility: a pilot study.

Authors:  Maria Antonietta Castiglione Morelli; Assunta Iuliano; Sergio Crescenzo Antonio Schettini; Donatina Petruzzi; Angela Ferri; Paola Colucci; Licia Viggiani; Flavia Cuviello; Angela Ostuni
Journal:  Metabolomics       Date:  2019-01-29       Impact factor: 4.290

4.  Attenuated AMH signaling pathway plays an important role in the pathogenesis of ovarian hyperstimulation syndrome.

Authors:  Lan Wang; Hemei Li; Jihui Ai; Jing Yue; Zhou Li; Hanwang Zhang; Yiqing Zhao
Journal:  Am J Transl Res       Date:  2015-10-15       Impact factor: 4.060

Review 5.  Polycystic ovarian syndrome and miscarriage in IVF: systematic revision of the literature and meta-analysis.

Authors:  Roberto Matorras; Jose Ignacio Pijoan; Lucía Laínz; María Díaz-Nuñez; Héctor Sainz; Silvia Pérez-Fernandez; Dayana Moreira
Journal:  Arch Gynecol Obstet       Date:  2022-09-04       Impact factor: 2.493

Review 6.  Follicular Fluid: A Powerful Tool for the Understanding and Diagnosis of Polycystic Ovary Syndrome.

Authors:  Ana Teresa Brinca; Ana Cristina Ramalhinho; Ângela Sousa; António Hélio Oliani; Luiza Breitenfeld; Luís A Passarinha; Eugenia Gallardo
Journal:  Biomedicines       Date:  2022-05-27

7.  A comparison of IVF outcomes transferring a single ideal blastocyst in women with polycystic ovary syndrome and normal ovulatory controls.

Authors:  Naama Steiner; Senem Ates; Talya Shaulov; Guy Shrem; Alexander Volodarsky-Perel; S Yehuda Dahan; Samer Tannus; Weon-Young Son; Michael H Dahan
Journal:  Arch Gynecol Obstet       Date:  2020-07-15       Impact factor: 2.344

8.  Low-dose hCG as trigger day and 35 hr later have different ovarian hyperstimulation syndrome occurrence in females undergoing In vitro fertilization: An RCT.

Authors:  Marzieh Aghahosseini; Ashraf Aleyasin; Venus Chegini; Victoria Chegini
Journal:  Int J Reprod Biomed       Date:  2017-11

9.  Characteristics and outcomes of in vitro fertilization in different phenotypes of polycystic ovary syndrome.

Authors:  Selçuk Selçuk; Enis Özkaya; Ahmet Eser; Melda Kuyucu; Hüseyin Tayfun Kutlu; Belgin Devranoğlu; Kenan Sofuoğlu; Vedat Erkan Dayıcıoğlu
Journal:  Turk J Obstet Gynecol       Date:  2016-03-10

10.  Prediction of severe ovarian hyperstimulation syndrome in women undergoing in vitro fertilization using estradiol levels, collected ova, and number of follicles.

Authors:  Ivan Madrazo; Monserrat Fabiola Vélez; Josue Jonathan Hidalgo; Ginna Ortiz; Juan José Suárez; Leonardo M Porchia; M Elba Gonzalez-Mejia; Esther López-Bayghen
Journal:  J Int Med Res       Date:  2020-08       Impact factor: 1.671

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.